Abstract:Licui Li, 1, 2 Huixiu Lu, 1, 3 Yanli Zhang, 4 Qian Li, 4 Shaomin Shi, 4 Yaling Liu 1, 4 1 Department of Dermatology and Venereology, Hebei Medical University, Shijiazhuang, People's Republic of China; 2 Department of Dermatology, Shijiazhuang Gaocheng People's Hospital, Shijiazhuang, People's Republic of China; 3 Department of Dermatology, Shijiazhuang People's Hospital, Shijiazhuang, People's Republic of China; 4 Department of Dermatology, The Third Hospital of Hebei Medical University, Shijiazhuang, People's Republic of China Correspondence: Yaling Liu, Department of Dermatology and Venereology, Hebei Medical University, Shijiazhuang, People's Republic of China, Email Objective: To probe into the effect of azelaic acid on psoriasis based on the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (AKT) signaling pathway. Methods: Psoriasis gene expression data were downloaded from the GEO database for differential expression analysis to identify differentially expressed genes (DEGs). KEGG and GSEA analyses were performed to identify important signaling pathways that may be involved in psoriasis progression for subsequent validation. Thirty-six C57BL/6 mice aged 8 weeks old were randomly assigned into the blank control group (n = 9), negative control group (n = 9), psoriasis model group (n = 9), and azelaic acid treat group (n = 9). Mice models of psoriasis were prepared with imiquimod (IMQ) in the latter two groups, and azelaic acid ointment was applied in azelaic acid treat group. Then, hematoxylin-eosin (HE) staining was carried out to detect the effect of azelaic acid on the pathological damage of mice models of psoriasis in each group. HaCaT cells cultured in vitro were divided into blank control group, negative control group (addition of azelaic acid), IL-17 group (20 ng/mL) and IL-17+azelaic acid group, with 3 replicates for each group. Immunofluorescence assay and Western blotting were used to detect the protein expression of PI3K/AKT signaling pathway related molecules. Results: KEGG analysis showed that DEGs were significantly enriched in PI3K-AKT signaling pathway. GSEA analysis showed that PI3K and MTOR signaling pathways were up-regulated in psoriasis, while AUTOPHAGY signaling pathway was down-regulated. HE staining showed that azelaic acid could significantly inhibit the local skin injury in mice caused by IMQ-induced psoriasis. Moreover, azelaic acid can inhibit the expression of PI3K/AKT signaling pathway related proteins phosphorylated (p)-PI3K, p-AKT, p-mammalian target of rapamycin (mTOR), vascular endothelial growth factor (VEGF), cyclooxygenase-2 (COX-2), angiogenin-1 and hypoxia-inducible factor-1α (HIF-1α). These results imply that azelaic acid may inhibit the activation of PI3K/AKT signaling pathway and angiogenesis, thereby improving the symptoms of psoriasis. Conclusion: Azelaic acid may inhibit the activation of PI3K/AKT signaling pathway and angiogenesis, thereby improving the symptoms of psoriasis. Keywords: psoriasis, azelaic acid, PI3K/AKT signaling pathway, angiogenesis Psoriasis is a chronic inflammatory dermatosis, which has strong genetic susceptibility and autoimmune pathogenic characteristics. 1 Currently, it is believed that psoriasis has an association with genetic, environmental, immune and other factors. It is mediated by the innate and adaptive immune systems, involves multiple links and pathways, and notably affects the health and quality of life of patients. 2,3 Phosphatidylinositol‐4,5‐bisphosphate 3‐kinase (PI3K)/protein kinase B (AKT) signaling pathway is a key pathway for cell survival and a typical autophagy-dependent transduction pathway, which is involved in cell growth, proliferation, vascular proliferation and other processes. 4 PI3K in cells can be activated by corresponding cytokines, further activating downstream AKT and related proteins and triggering corresponding cellular effects. In psoriasis, this pathway can regulate the upstream and downstream related targets together to induce pathological proliferation of epidermal cells. 5 In the upstream, tumor suppressor phosphatase and tensin homolog (PTEN) expression is down-regulated, and in the downstream, mammalian target of rapamycin (mTOR) is abnormally expressed. Inhibiting the PI3K/AKT signaling pathway can repress endothelial growth factors, thereby relieving the symptoms of psoriasis. 6 Azelaic acid gel is a common anti-inflammatory drug. It is mostly used in the treatment of acne, chloasma and cutaneous lesions caused by ultraviolet rays in clinic. 7–9 It can effectively improve the damaged skin barrier function of pati -Abstract Truncated-

Knockdown of Bcl-3 alleviates psoriasis and dyslipidemia comorbidity by regulating Akt pathway

UBE2L3 Reduces TRIM21 Expression and IL-1β Secretion in Epidermal Keratinocytes and Improves Psoriasis-Like Skin

LncRNA MEG3 suppresses PI3K/AKT/mTOR signalling pathway to enhance autophagy and inhibit inflammation in TNF-α-treated keratinocytes and psoriatic mice

A Potential Therapeutic Approach for Psoriasis Treatment

BML-111 Modulates and Alleviates p38/MAPK Signaling Pathway and Th1/Th2/Th17 Cytokine Response in Murine Psoriasis-Like Dermatitis

Tetrastigma hemsleyanum polysaccharides alleviate imiquimod-induced psoriasis-like skin lesions in mice by modulating the JAK/STAT3 signaling pathway

Transcription Coactivator BCL3 Acts as a Potential Regulator of Lipid Metabolism Through the Effects on Inflammation

Apigenin ameliorates imiquimod-induced psoriasis in C57BL/6J mice by inactivating STAT3 and NF-κB

Anti-interleukin 33 treatment alleviates psoriatic dermatitis in mice induced imiquimod

Knockdown of TRAF3IP2 Suppresses the Expression of VEGFA and the Proliferation of Keratinocytes and Vascular Endothelial Cells

Mannan‐binding lectin exacerbates the severity of psoriasis by promoting plasmacytoid dendritic cell differentiation via the signal transducer and activator of transcription 3–interferon regulatory factor 8 axis

Effect of Azelaic Acid on Psoriasis Progression Investigated Based on Phosphatidylinositol 3-Kinase (PI3K)/Protein Kinase B (AKT) Signaling Pathway

Suppression of IL-23-mediated psoriasis-like inflammation by regulatory B cells

Integrative bioinformatic analysis identified IFIT3 as a novel regulatory factor in psoriasis

Transglutaminase 3 attenuates skin inflammation in psoriasis by inhibiting NF-κB activation via p-STAT3-TET3 signaling.

Inhibition of Phospholipases Suppresses Progression of Psoriasis Through Modulation of Inflammation.

Protein inhibitor of activated STAT3 (PIAS3) attenuates psoriasis and associated inflammation

AMPK activation modulates IL‐36‐induced inflammatory responses by regulating IκBζ expression in the skin

MiR-193b-3p–ERBB4 axis regulates psoriasis pathogenesis via modulating cellular proliferation and inflammatory-mediator production of keratinocytes

Elevated cholesteryl ester transfer and phospholipid transfer proteins aggravated psoriasis in imiquimod-induced mouse models

A critical role of the endothelial S-phase kinase-associated protein 2/phosphatase and tensin homologue axis in angiogenesis and psoriasis